MUDr. Samuel Hricko
Instructor, Department of Physiology
Total number of publications: 11
2025
-
Advanced NGS analysis of cell-free tumor DNA supports clonal relation to primary high-grade B-cell lymphoma lesion and CNS relapse despite MRI negativity
Diagnostic Pathology, year: 2025, volume: 20, edition: 1, DOI
-
Diseminovaný hemangiosarkom imitující mnohočetný myelom
Česká radiologie, year: 2025, volume: 79, edition: 1, DOI
-
Reliable detection of CNS lymphoma-derived circulating tumor DNA in cerebrospinal fluid using multi-biomarker NGS profiling: insights from a real-world study
BIOMARKER RESEARCH, year: 2025, volume: 13, edition: 1, DOI
-
Risk of central nervous system versus systemic relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP: What should we focus on?
HemaSphere, year: 2025, volume: 9, edition: 9, DOI
2024
-
Detekce klinicky významné varianty genu MYD88 ve volné DNA získané z tekutých biopsií pacientů s lymfomy postihujícími centrální nervovou soustavu: likvor nebo plazma?
Year: 2024, type: Conference abstract
-
SENSITIVITA DETEKCE MYD88 L265P MUTACE VE VOLNÉ DNA Z LIKVORU PACIENTŮ S LYMFOMEM CNS A SROVNÁNÍ SE STANDARDNÍMI METODAMI PRŮKAZU CNS POSTIŽENÍ
Year: 2024, type: Conference abstract
-
The Genomic Landscape of Lymphomas Invading the Central Nervous System Inferred from Cell-Free DNA by Integrative NGS Analysis and the Diagnostic Benefit Compared to Flow Cytometry
Year: 2024, type: Conference abstract
2023
-
Do the Control Cohorts of Phase III Randomized Trials Reflect the Real-World Results of DLBCL Patients?
Blood, year: 2023, volume: 142, DOI
-
Genomic aberrations detected in circulating tumor DNA from cerebrospinal fluid and plasma of patients with primary and secondary CNS lymphomas with negative flowcytometry.
Year: 2023, type: Conference abstract
-
Risk of Central Nervous System Vs. Systemic Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: What Should We Focus on?
Blood, year: 2023, volume: 142, DOI